Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy development.
TUCSON, Ariz. May 6, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jeff Barrett, Ph.D., F.C.P., as Senior Vice President and lead for its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) initiative.Continue reading
WASHINGTON, D.C. – The MedTech Conference, powered by AdvaMed, will host its trademark award-winning programming and networking opportunities in a new hybrid structure, combining the benefits of both in-person and virtual events, on September 27th – 30th. Attendees can participate in The MedTech Conference in a fully virtual environment, and they can also take advantage of limited-capacity in-person gatherings in Washington, D.C. and in Minneapolis, Minnesota.Continue reading
Every mode of transportation—from the road, railway, ocean, and sky—is combating challenges testing the supply chain in new ways. Understanding the industry’s current climate and what lies ahead is the best way to navigate this rough road.Continue reading
TUCSON, Ariz.–(BUSINESS WIRE)–NuvOx Pharma has completed construction and initiated operation of its GMP production facility for manufacturing its injectable pharmaceutical products at its Tucson, Arizona facility. Construction of the GMP facility was financed by ImaRx Investments, LLC. The facility comprises an 1,800 square foot hard shell exterior space addition to the existing building located at 1635 East 18th Street. A 900 square foot ISO 5 cleanroom is housed within the exterior space.Continue reading
As the voice of Arizona’s Biotech and Medtech industry, AZBio shares information about our community and our innovators locally, nationally, and globally. Continue reading
The annual event is Arizona’s longest running Capital Conference and early-stage pitch competition, highlighting some of the most promising startups in the state. This year, the live competition will offer both in-person and virtual options and feature applicants chosen by an expert panel of judges.
On October 6-7, finalists will compete head-to-head in several industry categories and gain exclusive access to the region’s most active accredited investors.
Help spread the word among your networks and encourage any innovative, tech-based startups you know to apply!
With the acquisition, Castle expects to make available the most comprehensive molecular testing offering for difficult-to-diagnose melanocytic lesions.Continue reading
Merck will also donate more than $5 million in supplies and equipment to aid relief efforts in IndiaContinue reading